Ftse Mib
34.249,77
0,91%
DAX
18.161,01
1,32%
S&P 500
5.099,96
1,02%
NASDAQ Composite
15.927,90
2,03%
Bitcoin
63.892,62
0,76%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Assistenza
Home Investire Azioni U.S.A. NASDAQ Tonix Pharmaceuticals Holding Corporation (TNXP) Tonix Pharmaceuticals Holding Corporation (TNXP) Notizie

Tonix Pharmaceuticals Holding Corporation

TNXP
0,17
0,01005 (6,28%)
27 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
24/4/202414:00GLOBETonix Pharmaceuticals Announces Presentation at Planet..
01/4/202422:15GLOBETonix Pharmaceuticals Reports Fourth Quarter and Full Year..
28/3/202414:32GLOBETonix Pharmaceuticals Announces Pricing of $4.4 Million..
25/3/202413:00GLOBETonix Pharmaceuticals Receives Rare Pediatric Disease..
21/3/202413:00GLOBETonix Pharmaceuticals Announces Poster Presentation..
20/3/202413:00GLOBETonix Pharmaceuticals Announces Selection of Two Contract..
19/3/202413:00GLOBETonix Pharmaceuticals Announces Transition to Fully..
12/3/202413:00GLOBETonix Pharmaceuticals Announces Presentation at BIO-Europe..
11/3/202413:05EDGAR2Form 8-K - Current report
11/3/202413:00GLOBETonix Pharmaceuticals Reports Improvement in “Brain Fog,” in..
07/3/202415:37GLOBENew to The Street Announces TV Episode 560 with its Five..
07/3/202414:06EDGAR2Form 8-K - Current report
07/3/202414:00GLOBETonix Pharmaceuticals Announces Publication in Psychiatry..
06/3/202423:01EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
06/3/202414:05EDGAR2Form 8-K - Current report
06/3/202414:00GLOBETonix Pharmaceuticals Selects EVERSANA® to Support Launch..
05/3/202414:05EDGAR2Form 8-K - Current report
05/3/202414:00GLOBETonix Pharmaceuticals Announces Translation of Preclinical..
29/2/202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202423:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202423:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202423:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202414:00GLOBETonix Pharmaceuticals Announces Presentation at The 6th..
28/2/202414:06EDGAR2Form 8-K - Current report
28/2/202414:00GLOBETonix Pharmaceuticals Completes Clinical Stage of Phase 1..
27/2/202414:07EDGAR2Form 8-K - Current report
27/2/202414:00GLOBETonix Pharmaceuticals Announces Positive Results from..
23/2/202415:30GLOBENew to The Street Announces Line-up of its Corporate..
20/2/202414:00GLOBETonix Pharmaceuticals to Participate in the 2024 BIO CEO &..
16/2/202415:30GLOBENew to The Street Airs Episode 556 Featuring Five Corporate..
15/2/202423:02EDGAR2Form 8-K - Current report
14/2/202421:56EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202414:00GLOBETonix Pharmaceuticals Hosted KOL Webinar on Positive Phase 3..
13/2/202414:05EDGAR2Form 8-K - Current report
13/2/202414:00GLOBETonix Pharmaceuticals Announces Engagement of Rho as CRO to..
12/2/202414:00GLOBETonix Pharmaceuticals Announces FDA IND Clearance for DoD..
12/2/202413:06EDGAR2Form 8-K - Current report
31/1/202413:05EDGAR2Form 8-K - Current report
31/1/202413:00GLOBETonix Pharmaceuticals Announces Research Indicating..
29/1/202413:00EDGAR2Form 8-K - Current report
29/1/202413:00GLOBETonix Pharmaceuticals Announces Conditional Acceptance of..
25/1/202422:08EDGAR2Form 8-K - Current report
25/1/202413:00GLOBETonix Pharmaceuticals Announces KOL Webinar to Discuss..
19/1/202422:31EDGAR2Form 8-K - Current report
11/1/202422:53EDGAR2Form SC 13G - Statement of acquisition of beneficial..
09/1/202413:00GLOBETonix Pharmaceuticals Presents Additional Data Highlighting..
08/1/202423:07EDGAR2Form 8-K - Current report
08/1/202422:33EDGAR2Form DEF 14A - Other definitive proxy statements
03/1/202422:23EDGAR2Form SC 13G - Statement of acquisition of beneficial..
03/1/202413:00GLOBETonix Pharmaceuticals to Present at Two Upcoming Investor..
Apertura: 0,16 Min: 0,1597 Max: 0,1703
Chiusura: 0,15995

La tua Cronologia

NASDAQ
TNXP
Tonix Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network